Logo Connect to Care

Depression during adolescence can affect sleep, motivation, concentration, school attendance, relationships, physical health, family life and personal safety.

Psychotherapy, medication and coordinated family support remain important parts of adolescent depression care. Some adolescents, however, continue to experience significant major depressive disorder despite receiving appropriate treatment.

Transcranial Magnetic Stimulation, or TMS, is a noninvasive brain-stimulation treatment. Specific TMS devices have received FDA clearance as an adjunctive treatment for major depressive disorder in adolescent patients ages 15–21.

This clearance does not mean that every TMS system is cleared for adolescents. It also does not mean that TMS is cleared for every adolescent mental-health condition.

The exact indication depends on:

  • The TMS device

  • The coil

  • The treatment protocol

  • The patient’s age

  • The diagnosis

  • Safety screening

  • How TMS will be integrated with other care

This guide explains the FDA status of adolescent TMS, who may be evaluated, how treatment works, what families should know about safety, what happens during sessions, how outcomes may be monitored and how to ask informed questions before treatment.

Medical note: This article is educational and does not replace individualized medical advice, diagnosis, psychotherapy, medication management or treatment. Adolescent TMS requires diagnosis-specific evaluation, device- and protocol-specific review, safety screening, family involvement when appropriate and qualified clinical oversight.

Quick Summary

  • Specific TMS devices are FDA-cleared as adjunctive treatments for major depressive disorder in patients ages 15–21.

  • The first adolescent-specific clearance was issued in March 2024.

  • Clearance is specific to the device, coil, protocol, diagnosis and age range.

  • TMS is not broadly cleared for all teenagers or all adolescent mental-health conditions.

  • Use in patients under age 15 is outside these adolescent device indications.

  • TMS does not normally require surgery or general anesthesia.

  • Patients remain awake during sessions.

  • Common effects may include headache, scalp discomfort, tingling, facial twitching or lightheadedness.

  • Seizure is a rare potential risk.

  • Psychotherapy and medication may continue when clinically appropriate.

  • TMS should not replace emergency care or suicide-risk management.

  • Insurance coverage varies and may require prior authorization.

What Is Adolescent Depression?

Major depressive disorder involves persistent depression symptoms that interfere with daily life.

Symptoms may include:

  • Persistent sadness or irritability

  • Loss of interest or pleasure

  • Sleep changes

  • Appetite changes

  • Fatigue

  • Difficulty concentrating

  • Reduced motivation

  • Feelings of guilt or worthlessness

  • Social withdrawal

  • Falling school performance

  • Frequent physical complaints

  • Hopelessness

  • Thoughts of death or suicide

Depression can look different in adolescents than in adults. Irritability, withdrawal, school avoidance, changes in friendships, conflict, loss of motivation or physical complaints may be prominent.

A qualified clinician should evaluate symptoms rather than relying only on an online questionnaire or self-diagnosis.

Why Accurate Diagnosis Matters

Several conditions can produce symptoms that overlap with depression.

An evaluation may consider:

  • Anxiety disorders

  • Bipolar disorder

  • Trauma-related conditions

  • ADHD

  • Autism

  • Substance use

  • Eating disorders

  • Sleep disorders

  • Chronic pain

  • Medical conditions

  • Medication effects

  • Family or school stress

  • Grief

  • Psychosis

  • Learning difficulties

Bipolar disorder is particularly important to review because antidepressant treatment and brain stimulation may require different planning when mania or hypomania is present.

The clinician should also assess suicide risk and determine whether outpatient care is appropriate.

Established Treatments for Adolescent Depression

Treatment may include psychotherapy, medication, family support, school coordination and management of contributing health conditions.

Psychotherapy

Therapies used in adolescent depression care may include:

  • Cognitive behavioral therapy

  • Interpersonal psychotherapy

  • Family-focused approaches

  • Behavioral activation

  • Other evidence-based therapies selected by the clinician

Psychotherapy may help an adolescent address:

  • Negative thought patterns

  • Avoidance

  • Stress

  • Relationships

  • Problem-solving

  • Emotional regulation

  • Trauma

  • Relapse prevention

Medication

Certain antidepressants may be considered depending on age, diagnosis, symptoms, previous treatment and safety.

Medication decisions should be made by a qualified prescriber.

Families should understand:

  • Why a medication is recommended

  • How it should be taken

  • Possible side effects

  • What changes require urgent attention

  • How progress will be monitored

  • Why medication should not be stopped suddenly

Combined Care

Some adolescents may benefit from psychotherapy and medication used together.

TMS is described in adolescent device labeling as an adjunctive treatment, meaning it is considered alongside an appropriate broader treatment plan rather than automatically replacing therapy or medication.

What Is TMS?

Transcranial Magnetic Stimulation uses an electromagnetic coil positioned against the scalp to produce magnetic pulses.

These magnetic pulses pass through the skull and create small electrical currents in nerve cells beneath the coil.

During a standard session:

  • The adolescent remains awake.

  • The coil is positioned against the scalp.

  • The device produces clicking sounds.

  • Tapping or muscle movement may be felt.

  • Ear protection may be used.

  • Surgery is not required.

  • General anesthesia is not normally required.

For depression, treatment commonly targets the left dorsolateral prefrontal cortex, a region involved in mood regulation and connected brain networks.

The complete biological mechanism is still being studied.

For a practical appointment overview, read What Happens During a TMS Session?.

Is TMS FDA-Cleared for Adolescents?

Yes. Specific TMS systems are FDA-cleared as adjunctive treatments for major depressive disorder in adolescent patients ages 15–21.

The first adolescent-specific device clearance was issued in March 2024.

Additional TMS systems received similar adolescent MDD indications afterward.

The important point is that FDA clearance is specific to:

  • A named device

  • A particular coil or system configuration

  • A defined protocol

  • Major depressive disorder

  • Adjunctive use

  • Patients ages 15–21

Families should ask the provider:

  • What is the exact device name?

  • Is the device FDA-cleared for adolescent MDD?

  • Does the clearance cover the patient’s age?

  • Which coil will be used?

  • What protocol will be followed?

  • Is this treatment on-label or off-label?

  • What does “adjunctive” mean in this treatment plan?

What Does “Adjunctive Treatment” Mean?

Adjunctive treatment means TMS is incorporated into a broader clinical plan.

Depending on the adolescent’s needs, the plan may also include:

  • Psychotherapy

  • Medication management

  • Family involvement

  • School support

  • Sleep treatment

  • Nutrition or activity support

  • Safety planning

  • Treatment of anxiety, trauma or other conditions

  • Follow-up care

Adjunctive treatment does not mean that every patient must take medication. It means TMS is not presented as a complete replacement for appropriate mental-health care.

The clinical team should explain which treatments will continue and why.

Is TMS Cleared for Patients Under Age 15?

The adolescent device indications discussed on this page cover patients ages 15–21.

Treatment for a child younger than 15 would fall outside these adolescent indications and would require a separate off-label clinical assessment.

Evidence in younger children is more limited.

Families considering any off-label treatment should receive clear information about:

  • Why it is being proposed

  • What evidence supports it

  • What remains uncertain

  • Alternative treatments

  • Safety considerations

  • Who will monitor treatment

  • How outcomes will be measured

Is TMS Cleared for Every Adolescent Mental-Health Condition?

No.

The adolescent clearances apply to major depressive disorder under specific device labeling.

They do not automatically apply to:

  • Anxiety disorders alone

  • ADHD

  • Autism

  • PTSD

  • OCD

  • Bipolar depression

  • Eating disorders

  • Substance-use disorders

  • Psychosis

  • TBI-related symptoms

  • Chronic pain

  • Insomnia

Research may exist in some of these areas, but research use and FDA-cleared clinical use are not the same.

Who May Be Evaluated for Adolescent TMS?

An adolescent or young adult may be evaluated when:

  • Major depressive disorder has been diagnosed.

  • Symptoms are meaningfully affecting daily function.

  • Appropriate standard treatment has not provided enough improvement.

  • The patient falls within the age range of the proposed device indication.

  • The specific device and protocol are appropriate.

  • Safety screening does not identify a reason to avoid treatment.

  • The patient can attend repeated appointments.

  • The adolescent and family understand the benefits, limits and uncertainty.

  • A qualified clinician believes TMS may fit the treatment plan.

A diagnosis alone does not automatically make someone eligible.

What Should Be Reviewed Before Treatment?

The clinical evaluation may include:

  • Depression symptoms and duration

  • Current severity

  • Suicide risk

  • Previous psychotherapy

  • Previous medications

  • Medication response

  • Medication side effects

  • Bipolar-disorder history

  • Mania or hypomania

  • Psychosis

  • Anxiety

  • Trauma

  • ADHD or autism

  • Eating concerns

  • Substance use

  • Sleep

  • Headaches or migraines

  • Brain injury

  • Seizure history

  • Neurological conditions

  • Implanted devices

  • Metal fragments

  • Hearing concerns

  • Pregnancy considerations

  • School and family functioning

  • Ability to attend the treatment schedule

The treatment team should also understand who is responsible for medication management, psychotherapy and emergency support.

Consent, Assent and Family Involvement

Treatment of minors usually requires parent or legal-guardian consent, while the adolescent should also be meaningfully involved in understanding and agreeing to care.

The process may include discussion of:

  • Why TMS is being recommended

  • What treatment involves

  • Potential benefits

  • Possible side effects

  • Rare risks

  • Alternative treatments

  • Privacy and confidentiality

  • When parents or guardians must be informed

  • What happens if symptoms worsen

  • The expected schedule

  • Cost and insurance

  • How treatment may affect school and family routines

Young adults ages 18–21 can generally make their own healthcare decisions, although family support may still be valuable when the patient chooses to involve them.

How Does TMS Work for Depression?

TMS uses repeated magnetic stimulation to influence activity within targeted brain networks involved in mood regulation.

For depression, treatment commonly focuses on the dorsolateral prefrontal cortex.

Repeated stimulation may influence network activity and connectivity over time.

TMS does not:

  • Erase depression

  • Guarantee remission

  • Permanently correct brain chemistry

  • Repair every cause of adolescent depression

  • Work identically for every patient

Depression is influenced by biological, psychological, family, social, developmental and environmental factors. Treatment may need to address several of these areas.

What Does the Evidence Show?

The evidence base for adolescent TMS has grown, but it should be interpreted carefully.

The 2024 NeuroStar clearance used a large real-world data analysis involving adolescent patients, along with a literature review, to support the expanded age indication.

Research before and after that clearance has included:

  • Open-label studies

  • Real-world outcome analyses

  • Controlled trials

  • Safety studies

  • Systematic reviews

  • Studies of different stimulation protocols

Findings suggest that selected adolescents may experience depression-symptom improvement.

However:

  • Not every adolescent responds.

  • Some controlled studies have produced mixed findings.

  • Real-world data and randomized trials answer different questions.

  • Device and protocol differences matter.

  • Long-term evidence remains less extensive than adult evidence.

  • Results from one system should not automatically be applied to every system.

  • Improvement cannot be predicted for an individual patient.

What Outcomes May Occur?

Possible outcomes include:

  • Substantial symptom improvement

  • Partial improvement

  • Remission

  • Improved daily function

  • Limited improvement

  • No meaningful response

  • Initial improvement followed by recurrence

  • Treatment stopped because of burden or side effects

One response or remission percentage cannot predict what will happen for an individual adolescent.

Is TMS Safe for Adolescents?

Available evidence supports a generally favorable safety profile for appropriately selected adolescents treated with cleared devices and protocols.

Common side effects are usually local and treatment-related.

Possible common effects include:

  • Headache

  • Scalp discomfort

  • Tingling

  • Facial or scalp muscle twitching

  • Jaw or neck discomfort

  • Lightheadedness

  • Sensitivity to clicking sounds

  • Temporary discomfort during stimulation

The duration and intensity of these effects vary. Ongoing or worsening symptoms should be discussed with the clinical team.

Rare but Serious Risks

Seizure

Seizure is a rare potential risk.

Factors that may affect risk include:

  • Seizure history

  • Brain injury

  • Neurological conditions

  • Sleep deprivation

  • Alcohol or substance withdrawal

  • Certain medications

  • Recent medication changes

  • Stimulation settings

The clinical team should review risk factors before treatment and when health or medications change.

Mood Activation

Hypomania or mania may occur in susceptible individuals.

Possible warning signs include:

  • Reduced need for sleep

  • Unusually elevated energy

  • Racing thoughts

  • Risk-taking

  • Impulsive behavior

  • Unusual confidence

  • Severe irritability

  • Rapid or pressured speech

These changes require prompt clinical review.

Hearing Effects

TMS devices produce loud clicking sounds.

Appropriate hearing protection should be used according to the device instructions and clinic procedures.

New ringing, hearing changes or ear pain should be reported.

Worsening Psychiatric Symptoms

Depression, anxiety, agitation, suicidal thoughts, psychosis or other symptoms may worsen during a treatment period.

The patient and family should know how to report changes between sessions and where to obtain urgent help.

Does TMS Harm the Developing Brain?

Available clinical data has not established developmental brain damage as an expected effect of appropriately delivered adolescent TMS under cleared treatment conditions.

However, adolescent neurodevelopment is still ongoing, and long-term evidence is less extensive than the adult evidence base.

Families should receive a balanced explanation that:

  • Available safety data supports selected clinical use.

  • No medical treatment is risk-free.

  • Device and protocol matter.

  • Continued monitoring is necessary.

  • New cognitive, neurological or psychiatric symptoms require evaluation.

  • Long-term evidence is still developing, particularly for repeated, maintenance, accelerated, or off-label protocols. Continued monitoring and individualized clinical review remain important.

Does TMS Affect Memory or Learning?

TMS is not generally associated with the same memory-loss profile as ECT.

Clinical studies have not established progressive cognitive decline as an expected effect of standard TMS treatment.

Concentration or school performance may improve when depression improves, but this does not mean TMS directly enhances intelligence, memory or academic ability.

New or worsening concerns involving:

  • Memory

  • Attention

  • Language

  • Confusion

  • School performance

  • Headaches

  • Neurological function

should be evaluated by the treatment team.

What Happens During a TMS Session?

The exact procedure depends on the device and protocol.

A typical process may include:

1. Clinical Check-In

The treatment team may ask about:

  • Mood

  • Sleep

  • Medication changes

  • Side effects

  • Headaches

  • Anxiety

  • Suicidal thoughts

  • New medical concerns

2. Positioning

The adolescent sits in a treatment chair while the coil is positioned against the scalp.

3. Hearing Protection

Ear protection may be used because the device produces repeated clicking sounds.

4. Magnetic Stimulation

The device delivers magnetic pulses according to the selected protocol.

The patient may feel tapping, tingling or muscle movement.

5. Monitoring

The patient remains awake and can communicate with the treatment team.

6. Post-Session Check

The team may review headache, discomfort, dizziness, mood changes or other effects.

How Long Does Each Session Take?

Session length depends on the device and protocol.

Some sessions may take only several minutes, while other protocols may take approximately 20–40 minutes.

The first appointment may be longer because it can include:

  • Clinical review

  • Treatment mapping

  • Motor-threshold assessment

  • Positioning

  • Safety review

  • Explanation of the procedure

A shorter session does not automatically mean treatment is weaker or less effective.

How Many Sessions Are Needed?

There is no one schedule for every adolescent.

Treatment plans vary according to:

  • Device

  • Protocol

  • Diagnosis

  • Clinical response

  • Safety

  • Insurance authorization

  • Provider recommendations

Some depression protocols involve treatment on multiple weekdays over several weeks.

The number of sessions cannot guarantee when or whether improvement will occur.

Can Adolescents Attend School During TMS?

Many adolescents continue attending school during treatment, but daily or frequent clinic appointments can affect scheduling.

Families may need to consider:

  • Travel time

  • Appointment duration

  • School attendance

  • Homework

  • Fatigue

  • Headaches

  • Extracurricular activities

  • Transportation

  • Parent or guardian availability

A school accommodation plan may be helpful when treatment affects attendance or workload.

Any accommodation should protect the adolescent’s privacy while providing appropriate educational support.

Can an Adolescent Drive After TMS?

Many patients can resume normal activities after standard TMS because sedation is not normally used.

Driving depends on:

  • Age and licensing

  • Headache

  • Dizziness

  • Medication effects

  • Neurological symptoms

  • Emotional state

  • Provider instructions

An adolescent should not drive when symptoms or treatment effects could impair safety.

Can Medication Continue During TMS?

Many patients continue prescribed medication during TMS.

Medication changes should only be made by the prescribing clinician.

The treatment team should know about:

  • Prescription medication

  • Over-the-counter medication

  • Supplements

  • Recent dose changes

  • Missed doses

  • Alcohol or substance use

Medication changes may affect symptoms, safety and interpretation of treatment response.

Can Psychotherapy Continue?

Yes. Psychotherapy may continue when clinically appropriate.

TMS does not replace the skills and support provided by therapy.

Psychotherapy may help with:

  • Thought patterns

  • Avoidance

  • Family conflict

  • Stress

  • Trauma

  • Emotional regulation

  • Problem-solving

  • Relapse prevention

  • School and social functioning

TMS and psychotherapy can address different parts of the treatment plan.

What Happens if TMS Does Not Work?

If symptoms do not improve enough, the clinical team may reassess:

  • Diagnosis

  • Treatment adherence

  • Medication strategy

  • Psychotherapy

  • Sleep

  • Substance use

  • Medical conditions

  • Family or school stress

  • TMS protocol

  • Other treatment options

Other options may include:

  • Medication adjustment

  • More specialized psychotherapy

  • Intensive outpatient treatment

  • Family-focused care

  • ECT in selected severe cases

  • Ketamine or esketamine in appropriate circumstances

  • Sleep treatment

  • Higher-level psychiatric care

A limited TMS response does not mean that no treatment options remain.

How Long Do Benefits Last?

The duration of benefit varies.

Some adolescents may maintain improvement, while others experience symptom recurrence.

Follow-up care may involve:

  • Psychotherapy

  • Medication management

  • Sleep support

  • Family support

  • School coordination

  • Safety planning

  • Symptom monitoring

  • Discussion of repeat or maintenance treatment

There is no universal adolescent maintenance schedule.

Insurance and Cost

Insurance coverage varies by:

  • Plan

  • Diagnosis

  • Device

  • Protocol

  • Provider network

  • Age

  • Previous treatment history

  • Prior authorization

  • Medical-necessity rules

FDA clearance does not automatically guarantee insurance coverage. Coverage depends on the plan, diagnosis, device, protocol, provider network, age criteria, prior treatment, and authorization requirements.

Ask the insurer:

  • Is TMS covered for adolescent major depressive disorder?

  • Is the proposed device covered?

  • Is the proposed protocol covered?

  • What age criteria apply?

  • Is prior authorization required?

  • Which previous treatments must be documented?

  • Is the provider in network?

  • How many sessions are covered?

  • What is the deductible?

  • What are the copay and coinsurance?

  • Are repeat or maintenance sessions covered?

For broader financial guidance, review How Much Does TMS Cost?.

Suicide Risk and Emergency Care

Depression in adolescents can involve suicidal thoughts or behavior.

TMS is not a substitute for emergency psychiatric care.

Seek urgent help when an adolescent has:

  • Suicidal intent

  • A suicide plan

  • Access to lethal means

  • Inability to remain safe

  • Severe agitation

  • Acute psychosis

  • Severe mania

  • Catatonia

  • A medical emergency

In the United States:

  • Call or text 988 for the Suicide & Crisis Lifeline.

  • Call 911 or go to the nearest emergency department when there is immediate danger.

Parents and caregivers should take statements about suicide seriously and seek professional support promptly.

Questions Families Should Ask

Before beginning adolescent TMS, ask:

  • What is the confirmed diagnosis?

  • What standard treatments have been tried?

  • Why is TMS being recommended now?

  • What is the exact device?

  • Is the device FDA-cleared for ages 15–21?

  • Is the protocol cleared for adolescent MDD?

  • Is the treatment on-label or off-label?

  • What does adjunctive treatment mean in this case?

  • Will medication continue?

  • Will psychotherapy continue?

  • What safety screening will be completed?

  • What are the common side effects?

  • What are the rare risks?

  • How will suicide risk be monitored?

  • How will progress be measured?

  • How many sessions are proposed?

  • How will treatment affect school?

  • What happens if symptoms worsen?

  • What happens if treatment does not help?

  • What will insurance cover?

  • What will the family likely pay?

  • What follow-up care will be provided?

How Aurelius Approaches Adolescent TMS Inquiries

Aurelius evaluates brain-health inquiries within a broader clinical and human-performance context.

Families should contact Aurelius directly to confirm:

  • Whether adolescent evaluations are currently available

  • Which ages are accepted

  • Which TMS device is available

  • Whether its adolescent indication applies

  • Which clinicians oversee care

  • What safety screening is required

  • Whether TMS is offered independently or within a broader program

  • How outside therapists and prescribers are involved

  • Which insurance or funding pathways may apply

Families can review the general overview of TMS therapy in Harrisburg, PA and learn about the professionals involved through the Aurelius team.

Making an inquiry does not guarantee eligibility, treatment, insurance coverage or a particular outcome.

Frequently Asked Questions About TMS for Adolescents

Is TMS FDA-cleared for adolescent depression?

Specific TMS devices are FDA-cleared as adjunctive treatments for major depressive disorder in patients ages 15–21. Clearance does not apply to every device or protocol.

When was TMS first cleared for adolescent depression?

The first adolescent-specific TMS device clearance for adjunctive MDD treatment in patients ages 15–21 was issued in March 2024.

Is TMS cleared for children under 15?

The adolescent indications discussed here begin at age 15. Treatment below that age would be outside those indications and would require separate off-label clinical review.

Is TMS cleared for adolescent anxiety?

The adolescent clearances discussed here apply to major depressive disorder, not anxiety as a stand-alone diagnosis.

Does TMS replace medication?

Not necessarily. The adolescent indication is adjunctive, and many patients continue medication when clinically appropriate.

Does TMS replace psychotherapy?

No. Psychotherapy remains an important part of adolescent depression care.

Is TMS safe for teenagers?

Available evidence supports a generally favorable safety profile for appropriately selected patients treated with cleared devices and protocols. Common side effects and rare risks still require monitoring.

Can TMS cause a seizure?

Seizure is a rare potential risk. Safety screening and appropriate treatment parameters help reduce risk.

Does TMS harm the developing brain?

Available clinical data has not established developmental brain damage as an expected effect of properly administered adolescent TMS. Long-term evidence is less extensive than the adult evidence base, so continued monitoring remains important.

How long is each session?

Duration varies by device and protocol. Sessions may last several minutes or approximately 20–40 minutes.

How many sessions are required?

The schedule varies. Some protocols involve multiple sessions per week over several weeks.

Can teenagers attend school during treatment?

Many do, but frequent appointments, travel and side effects may require scheduling adjustments or school accommodations.

Does insurance cover adolescent TMS?

Coverage varies by plan, diagnosis, device, age, protocol, prior treatment and authorization requirements.

How can a family explore TMS at Aurelius?

Contact Aurelius to confirm current age eligibility, available devices, clinical oversight, safety screening and program fit.

Families can begin through Connect with Care.

Related Aurelius Resources

Explore Adolescent TMS at Aurelius

Adolescent TMS requires an accurate diagnosis, device-specific eligibility, careful safety screening, realistic expectations and coordination with appropriate mental-health care.

Aurelius can help families clarify:

  • Current age eligibility

  • Available TMS devices

  • FDA-cleared versus off-label use

  • Clinical screening

  • Treatment-session expectations

  • Family involvement

  • Cost and insurance questions

  • Appropriate next steps

Connect with Care

References

Leave a Reply

Your email address will not be published. Required fields are marked *